University of Utah Center for Clinical and Translational Science

本申请是对RFA TR-12-006的回应：“机构临床和转化科学奖 (U54)“，请求支持犹他州大学的临床和转化科学中心（CCTS）。 我们的CCTS建立在UU在遗传学和生物信息学方面的历史优势之上。我们对未来五年的愿景 维护和利用CCTS的服务核心，并将该基础架构用作跳板 启动新项目随着这一愿景的实现，我们将实现 FOA通过维持转化研究的家园来：（1）提高质量，数量，安全性， （2）提供资源和服务，以 支持和加速整个临床和转化研究的规划和实施 研究和社区的范围;（3）培训，导师，并支持下一代的翻译 研究人员通过成为主要研究人员和生产性教师的阶段;（4） 保持一个代表转化科学及其所有领域的治理结构， （5）参与持续评估，改进， 和创新。UU CCTS的使命是为以下方面提供支持： 翻译研究即使是可以被描述为“服务”的支持也将用于为创新提供信息 催化新思维此外，我们将把新的资源用于为 CTSA联盟在特定领域，即：人类遗传学;基因型/表型相关性;健康 服务研究，包括比较有效性;医疗器械创新;以及 将病历作为医疗保健和医学研究的工具提升到一个新的水平。我们会继续表演 研究旨在重新设计翻译研究的过程。 相关性（参见说明）; 提供资源和服务，以支持和加快临床和 在整个研究和社区范围内进行翻译研究。

This application, in response to RFA TR-12-006: "Institutional Clinical and Translational Science Award (U54)", requests support for the University of Utah's Center for Clinical and Translational Science (CCTS). Our CCTS is built upon the UU's historic strengths in genetics and bioinformatics. Our vision for the next five years is to maintain and leverage the service cores of the CCTS and use that infrastructure as a springboard to launch new programs. With implementation of this vision we will fulfill the Aims of the CTSA described in the FOA by maintaining a home for translational research to: (1) Increase the quality, quantity, safety, efficiency, and impact of translational research for all conditions; (2) Provide resources and services to support and speed the planning and implementation of clinical and translational research across the entire range of research and communities; (3) Train, mentor, and support the next generation of translational investigators through the stage of becoming principal investigators and productive faculty members; (4) Maintain a governance structure that represents the full spectrum of translational science and all of its stakeholders to effectively fulfill the Aims; (5) Engage in a process of continuous evaluation, improvement, and innovation in all of these areas. The mission of the UU CCTS will be to provide support for all aspects of translational research. Even support that can be characterized as "service" will be used to inform innovation and catalyze new thinking. In addition, we will direct new resources toward providing special expertise to the CTSA consortium in specific areas, namely: Human genetics; genotype/phenotype correlation; health services research including comparative effectiveness; medical device innovation, and; taking the electronic medical record to the next level as a tool for medical care and medical research. We will continue to perform research aimed at re-engineering the process of translational investigation. RELEVANCE (See instructions); Providing resources and services to support and speed the planning and implementation of clinical and translational research across the entire range of research and communities.